Sitravatinib Uses, Dosage, Side Effects and more

Sitravatinib is under investigation in clinical trial NCT03680521 (Neoadjuvant Sitravatinib in Combination With Nivolumab in Patients With Clear Cell Renal Cell Carcinoma).

Trade Name Sitravatinib
Generic Sitravatinib
Sitravatinib Other Names Sitravatinib
Type
Formula C33H29F2N5O4S
Weight Average: 629.68
Monoisotopic: 629.190831934
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: January 7, 2025 at 1:49 am

Innovators Monograph

*** Taking medicines without doctor's advice can cause long-term problems.
Share